135 related articles for article (PubMed ID: 31370746)
21. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
22. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors.
Segurado AC; Braga P; Etzel A; Cardoso MR
AIDS Patient Care STDS; 2004 Mar; 18(3):135-43. PubMed ID: 15104874
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
Lynch E; Falq G; Sun C; Bunchhoeung PDT; Huerga H; Loarec A; Dousset JP; Marquardt T; Paih ML; Maman D
BMC Infect Dis; 2021 Feb; 21(1):223. PubMed ID: 33637051
[TBL] [Abstract][Full Text] [Related]
27. Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study.
Derks L; Gassowski M; Nielsen S; An der Heiden M; Bannert N; Bock CT; Bremer V; Kücherer C; Ross S; Wenz B; Marcus U; Zimmermann R;
Int J Drug Policy; 2018 Sep; 59():54-62. PubMed ID: 30005420
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
29. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
[TBL] [Abstract][Full Text] [Related]
30. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
[TBL] [Abstract][Full Text] [Related]
31. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad.
Mohamed MK; Hussein MH; Massoud AA; Rakhaa MM; Shoeir S; Aoun AA; Aboul Naser M
J Egypt Public Health Assoc; 1996; 71(1-2):113-47. PubMed ID: 17217004
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico.
Burguete-García AI; Conde-González CJ; Jiménez-Méndez R; Juárez-Díaz Y; Meda-Monzón E; Torres-Poveda K; Madrid-Marina V
Salud Publica Mex; 2011; 53 Suppl 1():S7-12. PubMed ID: 21877076
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.
Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q
J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of hepatitis B surface antigen and anti HCV antibody and its associated risk factors among pregnant women attending maternity ward of Felege Hiwot Referral Hospital, northwest Ethiopia: a cross-sectional study.
Molla S; Munshea A; Nibret E
Virol J; 2015 Dec; 12():204. PubMed ID: 26626263
[TBL] [Abstract][Full Text] [Related]
35. Serological markers and risk factors for hepatitis B and hepatitis C viruses among students in a Nigerian university.
Forbi J; Pennap G; Silas-Ndukuba C; Agabi Y; Agwale S
East Afr J Public Health; 2009 Aug; 6(2):152-5. PubMed ID: 20000021
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
